Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00442598Phase 2Terminated
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
Ovarian Cancer
Principalinvestigator
NCT00501735Phase 2Completed
Forodesine in the Treatment of Cutaneous T-Cell Lymphoma
Cutaneous T-cell Lymphoma (CTCL),
Principalinvestigator

Research Network

Collaboration Network

27 collaborators·53 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Gabrail Cancer Center

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00442598Phase 2PrincipalInvestigator

Safety and Efficacy Study of Glufosfamide in Ovarian Cancer

Ovarian Cancer
Terminated
NCT00501735Phase 2PrincipalInvestigator

Forodesine in the Treatment of Cutaneous T-Cell Lymphoma

Cutaneous T-cell Lymphoma (CTCL),
Completed

All 2 trials loaded